Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Mediwound Ltd

MDWD ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$13.56

▲ +0.22%

Market Cap $175.06M · Vol 18.11K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$175.06M

Micro Cap

Div Yield

N/A

EPS Growth

-4.37%

YoY

RSI (14)

30.57

Momentum

Beta

0.14

vs Market

52W High

$20.30

33.20% below

52W Low

$13.46

0.74% above

Volume

18.11K

Avg 26.45K

P/B

4.56

Price-to-book

ROE

N/A

Return on equity

Free Float

77.29%

Public shares

Shariah Compliance8 STANDARDS

✗ Mediwound Ltd (MDWD) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MDWD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.77%

-4.84%

-19.26%

-21.48%

YTD

-26.54%

-26.98%

+51.00%

-44.97%

Financials & Valuation

TTM · Annual

Total Revenue	$16.96M
Net Income	$-23,879,000.00
Revenue Growth (YoY)	-62.71%
Gross Margin	19.19%
Operating Margin	-148.98%
Net Profit Margin	-140.80%
ROE	N/A
ROA · ROIC	-29.68% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	12.38
P/B	4.56
P/FCF	N/A
EPS Growth	-4.37%
Outstanding Shares	12.91M

Technical Indicators

50-Day SMA	$14.34
200-Day SMA	$16.63
RSI (14)	30.57
Beta	0.14
52-Week High	$20.30
52-Week Low	$13.46

Volume Today	18.11K
Avg Daily Volume (30D)	26.45K
Relative Volume	0.68x
Volatility (10D)	24.89
Volatility (30D)	25.19
Free Float	77.29%

Analyst Consensus

BUY

Current Price $13.56

Mean Target $29.83

52W Low$13.46 52W High$20.30

Current

Target

$13.46 $20.30

Current Analyst target

+120.01% upside potential · 6 analysts

Identifiers

ExchangeNasdaq

FIGIBBG005ZPKSG3

ISINIL0011316309

CountryIsrael

Sub-IndustryBiopharmaceuticals

Earnings DateNov 23, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.